Sports bioeconomy

01Overview and value chain#

Markers EC: US FDA wellness-device exemption + EU IVDR for at-home biomarker testing | OECD: Biotech and health | Regulator: FDA (USA), REACH framework (EU)

Sports bioeconomy covers the wearables, blood panels, genetic tests and at-home biomarker kits that turn an athlete’s own physiology into an actionable training signal, sold direct-to-consumer as a performance and recovery product rather than routed through a clinical diagnostic pathway. A modern recovery wearable derives daily readiness scores from continuously measured biomarkers (heart-rate variability, respiratory rate, skin temperature), while an at-home blood panel service tests dozens of biomarkers from a single draw and translates the results into specific training and nutrition recommendations. The category spans wearable recovery tracking, blood-panel performance testing, genetic tests linking specific gene variants to nutrition and training response, continuous glucose monitoring adapted from diabetes care to athletic fueling, and urine biomarker strips paired with a smartphone app for daily wellness tracking. Because these products are marketed and regulated as wellness or performance tools rather than medical devices, the category occupies a distinct regulatory and commercial lane from clinical diagnostics, even where the underlying biomarker assay technology overlaps.

The key directions of sports bioeconomy are:

1. Wearable recovery and readiness tracking: continuous biomarker measurement (heart-rate variability, respiratory rate, skin temperature) generates a daily recovery and readiness score without a blood draw.
2. Blood-panel performance testing: at-home or lab blood-draw services test dozens of biomarkers and translate results into specific training, nutrition and supplementation recommendations.
3. Genetic testing for nutrition and training response: DNA tests link specific gene variants to individual nutrition and exercise-response profiles, informing personalized training and diet plans.
4. Continuous glucose and urine biomarker monitoring: technology adapted from diabetes care (continuous glucose monitors) and at-home diagnostics (urine test strips) is repositioned for athletic fueling and daily wellness tracking.

Sectoral value chain#

[Athlete biomarker source] ──> [Measurement device/assay] ──> [Data collection]
                                                                        │
                                                              (biomarker interpretation)
                                                                        │
                                                                        ▼
[Training/nutrition recommendation] <─── [App/platform delivery] <─── [Personalized analysis]

Value chain levels#

Cross-cutting technologies of the sector:

• Continuous wearable biomarker sensing: heart-rate variability, respiratory rate and skin-temperature sensors generate a daily readiness score without requiring a blood draw, enabling continuous rather than point-in-time measurement.
• Direct-to-consumer blood-panel testing: at-home or retail blood-draw services test dozens of biomarkers in a single panel, translating lab results directly into consumer-facing training and nutrition guidance.
• Repositioned diagnostic technology: continuous glucose monitors developed for diabetes management and urine test strips developed for clinical screening are repositioned as athletic performance and wellness tools for a non-clinical consumer market.

02US#

The US hosts the leading wearable recovery-tracking company, an at-home blood-panel testing pioneer, a continuous-glucose-monitoring athletic performance company and a urine-biomarker wellness-testing company.

wearable recovery tracking, blood-panel testing, repositioned diagnostic technology#

• WHOOP: publishes dedicated content on recovery and performance biomarkers and cardiovascular biomarkers for athletes, positioning continuous wearable measurement specifically around training and heart-health guidance.
• InsideTracker: offers at-home and mobile blood-draw testing with an “Ultimate” membership tier, an established direct-to-consumer blood-panel testing pioneer in the category.
• Supersapiens: built the first continuous glucose-monitoring system specifically for athletic performance, repositioning diabetes-care sensor technology for non-clinical athletic fueling.
• Vivoo: offers a 9-in-1 urine test paired with a smartphone app tracking hydration, pH balance, ketone levels and other wellness biomarkers for daily use.

03CN#

No China-headquartered sports bioeconomy company cleared this screening round with confirmed, on-domain evidence.

import- and distributor-served market#

• Screening note: one candidate China-headquartered sports biomarker company was probed and did not return confirming, on-domain evidence this round — not asserted as absent, only as unconfirmed.

04EU#

This screening round did not confirm a European-headquartered sports bioeconomy company with on-domain evidence distinct from candidates checked elsewhere; the category currently reads as concentrated among US-headquartered wearable, blood-panel and diagnostic-repositioning companies.

screening limitation#

• Screening note: a UK-based sweat-testing candidate returned confirming evidence only through third-party competitor content rather than its own domain — a false-confirmation, dropped rather than tabled.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack layers continuous wearable sensing, direct-to-consumer lab testing and repositioned clinical-diagnostic technology on a common personalized-performance backbone.

1. Continuous wearable biomarker sensing:
   • Heart-rate variability, respiratory rate and skin-temperature sensors generate a daily readiness score without a blood draw, enabling continuous rather than point-in-time measurement.
   • Dedicated cardiovascular and recovery-biomarker content packages the underlying sensor data into athlete-facing training and heart-health guidance.
2. Direct-to-consumer blood-panel and genetic testing:
   • At-home or mobile blood-draw services test dozens of biomarkers in one panel, translating lab results into consumer-facing recommendations without a clinical visit.
   • Gene-variant testing links an athlete’s genetics to individual nutrition and training-response profiles, personalizing recommendations beyond what a one-size-fits-all blood panel alone provides.
3. Repositioned diagnostic technology for athletic use:
   • Continuous glucose monitors, originally developed for diabetes management, are repositioned as athletic fueling tools for a non-clinical consumer market.
   • Urine test strips paired with a smartphone app extend at-home diagnostic technology into daily wellness tracking outside a clinical screening context.

07Value chains and production pipelines#

Industrial pipeline of sports bioeconomy biomarker delivery (US FDA wellness-device exemption / EU IVDR)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Device/assay             │ ───> │ 2. Sample/signal            │
│    manufacturing            │      │    collection                │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Personalized analysis   │ <─── │ 3. Biomarker measurement    │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. App/platform delivery   │ ───> │ 6. Training/nutrition       │
│                             │      │    action                    │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Device/assay manufacturing

Wearable sensors, blood-panel test kits, genetic-test kits or urine test strips are manufactured to a defined measurement specification.

Stage 2: Sample/signal collection

The athlete wears the device continuously or provides a blood, saliva or urine sample.

Stage 3: Biomarker measurement

The device or laboratory processes the signal or sample into calibrated biomarker values.

Stage 4: Personalized analysis

Algorithms or lab interpretation translate biomarker data into an individual recommendation.

Stage 5: App/platform delivery

The personalized analysis is delivered to the athlete through a mobile app or web platform.

Stage 6: Training/nutrition action

The athlete adjusts training load, nutrition or recovery behavior based on the delivered recommendation.